Trial Profile
Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension (VDATH)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Colecalciferol
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VDATH
- 21 Nov 2011 New trial record